logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kazunori Honda

aichi cancer center
H指数:31
被引数:2,861

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and biomarker analysis for nivolumab in cancer of unknown primary: results from an investigator-initiated expanded access program

纳武利尤单抗治疗未知原发灶癌症的疗效与生物标志物分析：来自研究者发起的扩展性准入项目的结果

International Journal of Clinical Oncology
IF2.8
2026-09-240
OAAI
Junko Tanizaki; Kan Yonemori; Yuichi Takiguchi; Kohei Akiyoshi; Keigo Komine; Yusuke Onozawa; Mariko Sato; Kenro Hirata; Takuma Onoe; Ryotaro Ohkuma; Yosuke Horita; Hironobu Minami; Kazunori Honda; Koichi Suyama; Akihiko Ito; Yasutaka Chiba; Hiroko Watanabe; Yosuke Togashi; Kazuko Sakai; Kazuto Nishio; Kazuhiko Nakagawa; Hidetoshi Hayashi
Development of a visualization tool to estimate out-of-pocket costs for systemic cancer therapy in Japan and claims-based agreement evaluation: the VEST-Ca study

开发用于估算日本系统性癌症治疗自付费用及基于理赔数据的协议评估的可视化工具：VEST-Ca研究

Japanese Journal of Clinical Oncology
IF2.2
2026-08-010
PRE
Honda, Kazunori; Shimomura, Kazuhiro; Taniguchi, Hiroya; Kadowaki, Shigenori; Masuishi, Toshiki; Narita, Yukiya; Mizuno, Taro; Ando, Taiju; Ishizuka, Yasunobu; Umegaki, Sho; Ando, Masashi; Muro, Kei
Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with PD-L1 amplification: a case report

PD-L1扩增的食管鳞状细胞癌患者对作为免疫检查点抑制剂的尼鲁单抗再挑战治疗的反应：病例报告

Therapeutic Advances in Medical Oncology
IF4.2
2026-06-160
PRE
Hiroyuki Kodama; Toshiki Masuishi; Yasunobu Ishizuka; Tomoki Sakakida; Kazunori Honda; Yukiya Narita; Hiroya Taniguchi; Shigenori Kadowaki; Masashi Ando; Waki Hosoda; Kei Muro
Serum HER2 extracellular domain as a predictive biomarker for trastuzumab deruxtecan treatment response in HER2-positive gastric cancer: a real-world study

血清HER2胞外域作为预测曲妥珠单抗德鲁替康治疗反应的生物标志物：一项真实世界研究

Therapeutic Advances in Gastroenterology
IF3.4
2026-01-110
OA
Yukiya Narita; Ryosuke Kumanishi; Koshi Takahashi; Toshiki Masuishi; Hiroya Taniguchi; Shigenori Kadowaki; Kazunori Honda; Masashi Ando; Tadahisa Fukui; Masahiro Tajika; Kei Muro
Optimal Primary Prophylaxis for Febrile Neutropenia During Neoadjuvant Cisplatin and 5-Fluorouracil Plus Docetaxel for Esophageal Cancer: A Retrospective Cohort Study

奥沙利铂和5-氟尿嘧啶联合多西他赛新辅助治疗食管癌期间发热性中性粒细胞减少症的最佳一级预防：一项回顾性队列研究

CANCER MEDICINE
IF3.1
2025-04-240
OAAI
Kumanishi, Ryosuke; Taniguchi, Hiroya; Nakazawa, Taiko; Ogata, Takatsugu; Matsubara, Yuki; Kodama, Hiroyuki; Nakata, Akinobu; Honda, Kazunori; Masuishi, Toshiki; Narita, Yukiya; Kadowaki, Shigenori; Ando, Masashi; Tajika, Masahiro; Abe, Tetsuya; Muro, Kei
Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)
BRITISH JOURNAL OF CANCER
IF6.8
2023-11-168
OA
Minatogawa, Hiroko; Izawa, Naoki; Shimomura, Kazuhiro; Arioka, Hitoshi; Iihara, Hirotoshi; Sugawara, Mitsuhiro; Morita, Hajime; Mochizuki, Ayako; Nawata, Shuichi; Mishima, Keisuke; Tsuboya, Ayako; Miyaji, Tempei; Honda, Kazunori; Yokomizo, Ayako; Hashimoto, Naoya; Yanagihara, Takeshi; Endo, Junki; Kawaguchi, Takashi; Furuya, Naoki; Sone, Yumiko; Inada, Yusuke; Ohno, Yasushi; Katada, Chikatoshi; Hida, Naoya; Akiyama, Kana; Ichikura, Daisuke; Konomatsu, Akiko; Ogura, Takashi; Yamaguchi, Takuhiro; Nakajima, Takako Eguchi

研究方向

暂未获取到该数据
K
Kei Muro
H 指数:80论文数:1,040被引数:4.4万
S
Shigenori Kadowaki
H 指数:36论文数:420被引数:6,987
T
Toshiki Masuishi
H 指数:24论文数:324被引数:3,049
Y
Yukiya Narita
H 指数:20论文数:198被引数:1,969
M
Masashi Ando
H 指数:36论文数:310被引数:4,800
M
Masahiro Tajika
H 指数:46论文数:362被引数:7,645
T
Takatsugu Ogata
H 指数:11论文数:101被引数:428
Y
Yuki Matsubara
H 指数:11论文数:118被引数:476
H
Hiroya Taniguchi
H 指数:36论文数:433被引数:7,763
T
Taiko Nakazawa
H 指数:5论文数:55被引数:158